http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1316038
Outgoing Links
Predicate
Object
contentType
Journal Article
endingPage
2473
issn
1178-6930
pageRange
2463-2473
publicationName
OncoTargets and Therapy
startingPage
2463
bibliographicCitation
Fan S, Yan S, Yang Y, Shang J, Hao M. Actin-Like Protein 8 Promotes the Progression of Triple-Negative Breast Cancer via Activating PI3K/AKT/mTOR Pathway. Onco Targets Ther. 2021;14():2463–73. PMID: 33883901; PMCID: PMC8053609.
creator
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d8b39c225eb7375f15e28c41f58184b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c76b7152fe38e8520b157f03cf822f22
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a8db028679a3e07702f258154f6522de
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_67ae87120172d44e81aa2a80fb042786
date
202104
identifier
https://pubmed.ncbi.nlm.nih.gov/33883901
https://doi.org/10.2147/ott.s291403
https://pubmed.ncbi.nlm.nih.gov/PMC8053609
isPartOf
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37198
https://portal.issn.org/resource/ISSN/1178-6930
language
English
source
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title
Actin-Like Protein 8 Promotes the Progression of Triple-Negative Breast Cancer via Activating PI3K/AKT/mTOR Pathway
discussesAsDerivedByTextMining
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284616
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d0bb789479d34dbc0811f92fc2bc5049
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312145
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_78edc8e186d4ca89a5d99640d0f188ad
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c7be83279551b50c0e81dc2dbfe3c5d8
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11451
Total number of triples:
32
.